Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
galinpepimut-S +1 More for Acute Myeloid Leukemia
Recruiting1 awardPhase 1 & 2
Cincinnati, Ohio
This trial will test the safety and efficacy of a new cancer treatment combining galinpepimut-S with pembrolizumab. Up to 90 patients will be enrolled, and treatment will last for a maximum of 2.13 years.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.